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Introduction
Osteosarcoma is the most common primary bone malignancy [1] . Osteosarcoma predominately affects adolescents and young adults [2] . The predominant therapy of osteosarcoma is multiagent chemotherapy, and the prognosis is very poor [3] [4] [5] [6] [7] [8] .
RNA extraction and Real time q-PCR
RNA was extracted with Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The cDNA synthesis and real-time qPCR were subsequently performed using the Qiagen system as described detail in our previous studies [18, 21, 22] . Real-time quantitative PCR analysis was performed using standard protocols on an Applied Biosystem's 7500 HT sequence Detection System. MiR-3928 expression was assessed using a mirVana TM qRT-PCR miRNA Detection Kit (Ambion, USA). The primers were designed and synthesized by Shengong Company (Shanghai). The primers of potential target genes were list: ERBB3, F AAGGCCCTTTAATGTGGGGG, R CTCCCATCAGACAACAGTGCT; CDK6 F CTGCAGGGAAAGAAAAGTGCAA, R CAAGACTTCGGGTGCTCTGT; CDK13 F AGGCTCTTCAGTGCGAGTTC, R TGTCCAGGGCCTGTTTTTACA; IL-6R F TCACTGTGTCATCCACGACG; R AGCCAGCTATCTGGGGAAGA; MLL2 F GGCCAAATGGGAAGCAACTG, R GACGTGTGTCCACTCGTTCT; GAPDH F CGCTCTCTGCTCCTCCTGTT, R CCATGGTGTCTGAGCGATGT. U6 F GTGGACCGCACAAGCTCGCT, R TTGTTGAACGGCACTGTGTATAGCA.
Luciferase reporter assay
The 3'UTR reporter plasmid (RL-control, RL-ERBB3, RL-CDK6, RL-CDK13, RL-IL-6R and RL-MLL2) were constructed by Shengong Company (Shanghai). RL reporter plasmids (3.6fmol) and pGL3-control (500ng for normalization; Promega) were transfected with Lipofectamine 2000 (Invitrogen) into HEK293 cells (6×10 4 cells per well). Cells were collected after 48h for assay using the Dual Luciferase reporter assay system (Promega) [23] . The primers for 3'UTR cloning were list: ERBB3, F GCTTCTTCACAGGCACTCCT, R GGATGTGGCTGTTGGGGTTA; CDK6 F ACACCCTTGGTGGCTTATGG, R AGGCGGTTTCCTTGGAGAAG; CDK13 F GGCATAAGCCTTTTATGGCCC, R GGGAGGGGCTGTTTGTTACAT; IL-6R F GGGAAAAACCAGCGTGTGAC; R ATCCTTTCGCACCTGTCTGG; MLL2 F CCCACAGGAACCGCTGTAAT, R CCAATCTCCCCCTCCCTGTA
MiRNAs mimics and miRNAs antisense oligonucleotides transfection
MiR-3928, miRNAs mimics and miRNAs antisense oligonucleotides (ASO) were obtained from GenePharma (GenePharma, China). MiRNAs mimics, ASO, negative control (NC) were transfected into cells at a concentration of 50nM using Lipofectamine 2000 (Invitrogen, Canada) transfection reagent according to the manufacturer's instructions. 48h later cells were collected for further experiments. The sequence of mimics and ASO were list: Mimics GGAGGAACCUUGGAGCUUCGGC, Antisense oligonucleotides UGAAGCUCUAAGGUUCCGCCUGC; NC sense strand UUCUCCGAACGUGUCACGUTT; NC antisense strand, ACGUGACACGUUCGGAGAATT
MicroRNAs targets prediction
TargetScanHuman (http://www.targetscan.org/vert_61/) [24] [25] [26] [27] and miRbase [28] is applied to identify the potential target of miR-3928. The script of miR-3928 was list : 37-ggaggaaccuuggagcuucggc-58.
Statistical Analysis
Data were presented as the mean ± s.d (standard deviation). from at least three independent experiments. The difference between two groups was analyzed using two-tailed Student's t test. Correlation 
Results

Down-regulation of miR-3928 in osteosarcoma
To identify the role of miR-3928 in osteosarcoma, we firstly assayed the miR-3928 level in osteosarcoma tissues and corresponding adjacent normal tissues by qRT-PCR. We found that the level of miR-3928 was lower in osteosarcoma tissue than in normal tissues in the 10 pairs (Fig. 1A) . And the mean expression of miR-3928 in osteosarcoma tissues was about 60% expression level of miR-3928 in corresponding adjacent normal tissues (Fig. 1B) . The miR-3928 expression in osteosarcoma cell lines was assayed by qRT-PCR. We found that osteosarcoma cell lines (U2OS, Saos-2 and MG-63) showed a lower miR-3928 expression as comparing with human osteoblast cell lines (HOb) (Fig. 1C) . So, miR-3928 was downregulated in vivo and in vitro in osteosarcoma.
Over-expression of miR-3928 inhibited tumor growth
To investigate the role of miR-3928 in osteosarcoma, we over-expressed the miR-3928 in U2OS and MG-63 cell lines by miRNA mimics transfection. After 48h transfection, miR-3928 in U2OS and MG-63 were over-expressed up to 6-8 folds (Fig. 2A) . Then ,we assayed cell proliferation, apoptosis rate and cell cycle of these two cell lines. We found that overexpression of miR-3928 inhibited U2OS and MG-63 cells proliferation (Fig. 2B) . FACS analysis revealed that after miR-3928-mimics transfection, the apoptosis rates were increased in the both cell lines (Fig. 2C) . Cell cycle analysis showed that mimics transfection increased the percent of cells in G1 phrase and decreased the percent of cells in S phrase. Thus our data indicated that over-expression of miR-3928 inhibited osteosarcoma cells growth. 
were inversely correlated with miR-3928 expression in osteosarcoma tissues (Fig. 5B) . Collectively, these results implied that ERBB3, IL-6R and CDK6 in osteosarcoma tissues could be negatively regulated by miR-3928.
Discussion
This may be the first time to reveal the role of miR-3928 in cancer. We found that the anti-cancer role of miR-3928 in osteosarcoma. Our data indicated that miR-3928 may inhibited cell proliferation, induced cell apoptosis in osteosarcoma. In a previous study, ionizing radiation induced the expression of miR-3928 that suppressed Dicer expression and subsequently inhibited the maturation of miRNAs including miR-3928. The oscillation of Dicer and miR-3928 expression then provided cells a fine tuning process to respond to DNA damage and return to a balance after DNA damage is repaired, which is an important process in DNA damage signaling transduction [15] . Here, in osteosarcoma tissues, the level of miR-3928 was down-regulated, and over-expression of miR-3928 inhibited tumor growth. It seemed that in osteosarcoma, the fine tuning role of miR-3928 was gone. The reasons we concluded may be the balance of miR-3928 and Dicer were broken and the loss of Dicer function resulted the malfunction of other miRNAs. We will investigate the role of Dicer in osteosarcoma in further study.
Our data showed that the targeted genes involved were ERBB3, IL-6R and CDK6. ERBB3 belonged to the ERBB family, and played an important role in the growth of various organs [29] , including the bone tissue [30, 31] . The activated role of ERBB3 has been confirmed in osteosarcoma, ERBB3 expression in osteosarcoma cells increased with the incidence of metastasis, particularly in cases of recurrence, and the ERBB3 expression correlated with tumor invasion and patient outcome [32] . Our results may provide a reason why ERBB3 was up-regulated in osteosarcoma.
Interleukin-6 (IL-6) is a multifunctional cytokine which plays an important role in a wide range of biologic activities in different types of cell including tumor cells. These effects Fig. 4 . MiR-3928 targeted genes predication. Putative targeted genes were predicated by bioinformatics analysis, the binding site of four putative targeted were showed (A). The RL reporter plasmids (RL-control, RL-ERBB3, RL-CDK6, RL-CDK13, RL-IL-6R and RL-MLL2) and miR-3928 or miR-NC were cotransfected into HEK293 cells, along with a firefly luciferase reporter (pGL control) for normalization. Luciferase activities were measured after 48h. Then the ratio of RL activity of firefly luciferase activity in miR-3928 treated group were calculated and compared with the ratio in miR-NC group (which was arbitrary defined as 100%). Data are mean±s.d. of three separate experiments. *P<0.05.
